Department of Veterans Affairs awards $6.2 million to VA Providence for Neurological Research to advance Veterans Health


PROVIDENCE, R.I. – The Department of Veterans Affairs has approved a research award of $6.2 million, effective June 1, 2023, for the VA Providence Healthcare System to support a full range of translational research, from understanding basic mechanisms of nervous system function to developing and implementing novel treatments for complex neurological and mental health disorders.

The funding supports the VA Rehabilitation Research and Development Service (RR&D) Center for Neurorestoration and Neurotechnology (CfNN) located at VA Providence Healthcare System. The funding represents the 2nd renewal for CfNN, which was first funded in 2012.

“We are extremely fortunate to have world class research conducted by extremely talented researchers and scientists here at the VA Providence Healthcare System,” says Lawrence Connell, VA Providence Healthcare System Director, “our research will ultimately improve the lives of our Veterans and the general public at large,” he said.

CfNN is one of 12 centers funded by VA RR&D dedicated to advancing Veterans Health through neuroengineering and clinical neurorehabilitation research.  CfNN’s vision is to improve the physical function, mental health and functioning, and quality of life of Veterans. Since 2012, CfNN has facilitated deeply collaborative research between its scientists, VA Providence and other RR&D Center researchers, and CfNN’s university and hospital affiliates.

“The multidisciplinary cutting-edge research done by investigators at CfNN has the potential to dramatically improve the lives of our Veterans suffering from neurological and mental health disorders and disabilities. With this renewal, our research team at VA Providence will continue in their endeavor to bring novel device-based therapies from research labs to the clinic,” said Gaurav Choudhary MD, Associate Chief of Staff (Research) at VA Providence. 

CfNN is led by Leigh R. Hochberg, MD, PhD who is a neurologist at the VA, the L. Herbert Ballou University Professor of Engineering and Professor of Brain Science at Brown University, and director of the Center for Neurotechnology and Neurorecovery at Massachusetts General Hospital. He was the recipient of the 2022 VA Paul B. Magnuson Award, the highest research award in VA RR&D.  “Restoring communication, mobility, mental health, and limb and sensory function are key priorities for Veterans Health. We are thrilled to have the opportunity to continue our research to develop new neurotechnology-based therapies to improve the health and function of Veterans with neurologic or mental health disorders, and to help recruit and advance the next generation of neurorestoration researchers,” said Dr. Hochberg. Benjamin Greenberg, MD, PhD, CfNN’s Associate Director and Professor of Psychiatry and Human Behavior at Brown, said, “This is an incredibly exciting time for making real differences in brain and behavioral disorders for Veterans. We are getting better at understanding how functioning in circuits in the brain give rise to mental health or neurologic disorders. And advances in technology promise to allow us to engage those brain pathways to relieve suffering and improve the lives of Veterans with these illnesses. We’re honored to be able to continue CfNN’s work to support our nation’s Veterans and others with neurologic disease or injury.”

Patricia A. Dorn, PhD, VA’s Director of RR&D, said, “It is vital to continue to support the research and mentoring conducted by the outstanding CfNN team of investigators as they make groundbreaking discoveries to improve the lives of Veterans with neurological and mental health conditions. Through the Leadership of Drs. Hochberg and Greenberg, CfNN successfully carries out its mission for Veterans to develop, test, and implement new therapies and technologies to restore function in disorders of the nervous system that impair movement, emotion, or cognition.”

For more information about the center, please see





The last night of the Republican National Convention will be all about Donald Trump. The former President is set to take the stage in Milwaukee tonight to formally accept the GOP nomination for the White House. It'll be the first time he addresses the nation since surviving an attempt on his life Saturday. Trump will lay out what the campaign says is his plan for a new golden age for America.        President Biden has COVID. The White House says Biden tested positive following an event in Las Vegas in which he was not feeling well. The president is experiencing mild symptoms and will return to Delaware, where he'll self-isolate.        Three people are dead after severe storms hit the Midwest and East Coast yesterday. One person died in New York around 25 miles east of Syracuse. The two others were killed in Illinois after a flood carried their car away. A cold front moving into the East Coast could create more severe thunderstorms and heavy rain through the rest of the week.        New Jersey Senator Bob Menendez is rejecting a report that says he will resign following his conviction on federal corruption charges. Sources tell NBC News that Menendez told close allies he plans on stepping down. However, Menendez tells CBS 2 that he has not spoken with any so-called allies and that it seems to him that there is an effort to try to force him into a statement.        An Illinois sheriff's deputy is being charged in the deadly shooting of a Black woman. Authorities say Sonya Massey called 911 on July 6th to report a possible intruder in her home in Springfield. Sangamon County Sheriff's Deputy Sean Grayson and another deputy went to Massey's home, where Grayson shot and killed the woman. He's been indicted on multiple charges, including murder.        The Open is underway in Scotland. The year's last major event is taking place at the Royal Troon Golf Course in Troon. Brian Harman won last year's title and he's back in the fold once again. Justin Thomas has shot the lowest score of the day so far, finishing three shots under par and in first place.